A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer

M.H. Cullen, Petr Zatloukal, S Sörenson, Silvia Novello, J.R. Fischer, Anil A. Joy, Manuela Zereu, Patrick Peterson, Carla Visseren‐Grul, N. Iscoe

Annals of Oncology · 2008 · 73 citations · 24 references

Concepts

References

24